NCT00000733View on ClinicalTrials.gov

Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 1991

Conditions

HIV Infections

Interventions

DRUG

Ribavirin

Trial Locations (2)

70112

Charity Hosp / Tulane Univ Med School, New Orleans

Tulane Univ School of Medicine, New Orleans

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000733 - Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients | Biotech Hunter | Biotech Hunter